Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Not Applicable

Completed

• Conditions: Influenza; Vaccine-Preventable Diseases; COVID-19; Vaccine Hesitancy; Health Behavior; Colorectal Cancer; Healthcare Patient Acceptance
• Interventions: Behavioral: Financial incentive for colorectal cancer screening; Behavioral: Financial incentive for flu shot; Behavioral: Financial incentive for COVID-19 shot

• Registration Number: NCT06124131
• Lead Sponsor: Tulane University

Brief Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:

* Do patient financial incentives for completing colorectal cancer screening increase screening completion?

* Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?

Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.

Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2023-11-03
• Study First Submitted QC: 2023-11-03
• Study First Posted: 2023-11-09
• Study Start: 2023-11-11
• Primary Completion: 2024-03-25
• Study Completion: 2024-03-25
• Results First Submitted: 2025-03-25
• Status Verified: 2025-04
• Results First Submitted QC: 2025-04-16
• Last Update Submitted: 2025-04-16
• Results First Posted: 2025-05-04
• Last Update Posted: 2025-05-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Age 45 to 75
• Receive care at participating primary care clinic
• Due for colorectal cancer screening
• Ability to understand and speak English

Exclusion Criteria

• Currently participating in another clinical trial or research study on colorectal cancer screening
• Unable or unwilling to give informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Full financial incentives	Financial incentive for colorectal cancer screening	$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening
Full financial incentives	Financial incentive for flu shot	$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening
Full financial incentives	Financial incentive for COVID-19 shot	$50/service patient financial incentive for completion of: COVID-19 shot, flu shot, colorectal cancer screening
Partial financial incentives	Financial incentive for flu shot	$50/service patient financial incentive for completion of: COVID-19 shot, flu shot
Partial financial incentives	Financial incentive for COVID-19 shot	$50/service patient financial incentive for completion of: COVID-19 shot, flu shot

Primary Outcome Measures

Name	Time	Method
Difference in Percent of Participants Completing Colorectal Cancer Screening Between Study Arms	Two months	Completion of colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test as documented in electronic health record within two months of study enrollment

Secondary Outcome Measures

Name	Time	Method
Difference in Percent of Participants Completing COVID-19 Shot Between Study Arms	Two months	Completion of COVID-19 shot as documented in electronic health record within two months of study enrollment
Difference in Percent of Participants Completing Flu Shot Between Study Arms	Two months	Completion of flu shot as documented in electronic health record within two months of study enrollment
Difference in Percent of Participants Completing at Least One of the Following Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	Two months	Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*OR\* flu shot as documented in electronic health record within two months of study enrollment
Difference in Percent of Participants Completing All Three Services Between Study Arms: Colorectal Cancer Screening, COVID-19 Shot, Flu Shot	Two months	Completion of colorectal cancer screening (colonoscopy, sigmoidoscopy, CT colonography, or stool-based colorectal cancer screening test), COVID-19 shot, \*AND\* flu shot as documented in electronic health record within two months of study enrollment

Trial Locations

Locations (1)

Tulane University School of Medicine; 🇺🇸 New Orleans, Louisiana, United States